CYP19A1 and disease of the tendon: Compared with the incidence of tendon disorders in patients who used fluoroquinolones without statins, aromatase inhibitors, and glucocorticoids, the incidence of tendon disorders in patients who used any of these three drug types was more than 10-fold (Supplementary Table S3).